Navigation Links
Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007
Date:2/29/2008

nded December 31, 2007.

WARNER CHILCOTT LIMITED

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands of U.S. dollars)

(Unaudited)

As of As of

December 31, December 31,

2007 2006

ASSETS

Current assets:

Cash & cash equivalents $30,776 $84,464

Accounts receivable, net 65,774 74,287

Inventories 54,031 66,376

Prepaid expenses & other current assets 65,735 70,678

Total current assets 216,316 295,805

Other assets:

Property, plant and equipment, net 57,453 46,035

Intangible assets, net 1,329,427 1,533,757

Goodwill 1,250,324 1,241,452

Other non-current assets 31,454 45,496

TOTAL ASSETS $2,884,974 $3,162,545

LIABILITIES

Current liabilities:

Accounts payable $17,883 $23,094

Accrued expenses & other current

liabilities 196,362 136,101

Current portion of long-term debt 8,284 11,790

Total current liabilities 222,529 170,985

Other liabilities:

Long-term debt, excluding current

portion 1,191,955 1,538,960

Other non-current liabilities 116,070 124,368


'/>"/>

SOURCE Warner Chilcott Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related biology technology :

1. Warner Chilcott Announces Earnings Release Date and Conference Call for Fourth Quarter and Full Year 2007 Financial Results
2. Warner Chilcott and Watson Pharmaceuticals Announce Launch of Tilia(TM) Fe
3. Warner Chilcott Announces Earnings Release Date and Conference Call for Third Quarter 2007 Financial Results
4. Warner Chilcott Announces New Information in USPTO Reexamination of Taclonex Patent
5. Warner Chilcott Announces Receipt of Paragraph IV Certification Notice
6. Cepheid Reports Fourth Quarter and Full Year 2007 Results
7. Strategic Diagnostics Reports Fourth Quarter and Full-Year Financial Results
8. US Oncology Reports Fourth Quarter and Fiscal Year 2007 Results
9. Barr Reports GAAP Earnings of $1.18 Per Share for 2007 and $0.30 Per Share for the Fourth Quarter; Adjusted Earnings Were $3.16 Per Share for 2007 and $0.79 Per Share for the Fourth Quarter
10. Masimo Reports Fourth Quarter 2007 and Full Year 2007 Financial Results
11. eResearchTechnology Reports Fourth Quarter and Full Year 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... -- Technology Applications International Corporation (the "Company" or "NUUU")(OTC BB: ... Inc. has signed an additional exclusive licensing agreement with ... Johnson Space Center in Houston , ... Charles J. Scimeca , NUUU,s ... latest, exclusive agreement with NASA. In addition to our ...
(Date:9/2/2014)... 2, 2014  Xencor, Inc. (NASDAQ: ... monoclonal antibodies for the treatment of autoimmune diseases, ... the appointment of Debra Zack , M.D., ... of Lloyd Rowland , senior vice president, ... "Debra,s expertise in biologics clinical development and ...
(Date:9/2/2014)... 02, 2014 PMG Research, Inc ... clinical research site: PMG Research of Rocky Mount. Effective ... of the clinical research department at Boice-Willis Clinic ... in eastern North Carolina. This new site enhances PMG’s ... in Rocky Mount and the surrounding communities, this brings ...
(Date:9/1/2014)... Sept. 1, 2014 Reportlinker.com announces that ... its catalogue: India Solid Waste Management ... http://www.reportlinker.com/p02350445/India-Solid-Waste-Management-Vehicles-Market-Forecast-and-Opportunities-2019.html In ... main governing bodies responsible for complete handling and ... an average, around 135,000 MT solid waste is ...
Breaking Biology Technology:Technology Applications International Corporation Subsidiary Enters Into Additional Exclusive Agreement with NASA at a Signing Ceremony at the Johnson Space Center In Houston, Texas 2Technology Applications International Corporation Subsidiary Enters Into Additional Exclusive Agreement with NASA at a Signing Ceremony at the Johnson Space Center In Houston, Texas 3Xencor Appoints Debra Zack, M.D., Ph.D., Vice President, Clinical Development and Lloyd Rowland, Senior Vice President, Chief Compliance Officer and General Counsel 2Xencor Appoints Debra Zack, M.D., Ph.D., Vice President, Clinical Development and Lloyd Rowland, Senior Vice President, Chief Compliance Officer and General Counsel 3PMG Research Announces the Formation of its Eleventh Site 2PMG Research Announces the Formation of its Eleventh Site 3India Solid Waste Management Vehicles Market Forecast and Opportunities, 2019 2India Solid Waste Management Vehicles Market Forecast and Opportunities, 2019 3India Solid Waste Management Vehicles Market Forecast and Opportunities, 2019 4India Solid Waste Management Vehicles Market Forecast and Opportunities, 2019 5India Solid Waste Management Vehicles Market Forecast and Opportunities, 2019 6India Solid Waste Management Vehicles Market Forecast and Opportunities, 2019 7India Solid Waste Management Vehicles Market Forecast and Opportunities, 2019 8
... ... added another 20,000 jobs. Layoffs were also down overall, although the pharmaceutical industry reported ... ... in February, health care continued to add jobs, with growth of more than 20,000, according ...
... inflammation in cardiovascular and other diseases, it is essential to ... the body -- and the genes that regulate them. ... Proceedings of the National Academy of Sciences suggests that ... role in inducing and mediating an inflammatory response in cells ...
... on silicon-carbon nanocomposite materials could significantly improve the ... range of applications from hybrid vehicles to portable ... self-assembly technique, the new structure takes advantage of ... shortcomings of earlier silicon-based battery anodes. The ...
Cached Biology Technology:The MedZilla Report for March 2010 - Layoffs Down in February Despite Merck Merger; Health Care Employment Up Again 2The MedZilla Report for March 2010 - Layoffs Down in February Despite Merck Merger; Health Care Employment Up Again 3The MedZilla Report for March 2010 - Layoffs Down in February Despite Merck Merger; Health Care Employment Up Again 4Researchers identify a gene that may play a key role in atherosclerosis and other diseases 2Researchers identify a gene that may play a key role in atherosclerosis and other diseases 3Lithium-ion anode uses self-assembled nanocomposite materials to increase capacity 2Lithium-ion anode uses self-assembled nanocomposite materials to increase capacity 3
(Date:9/2/2014)... new study that could ultimately lead to many new ... Research Institute (TSRI) have adapted a chemical approach to ... that can treat a form of muscular dystrophy. , ... a disease-causing defect as a catalyst to synthesize a ... Disney.,"Because the treatment is synthesized only in diseased cells, ...
(Date:9/2/2014)... essentially the same DNA sequence their genetic information. ... cells in the different parts of the body are ... construction master plan, an additional regulatory layer exists that ... active. This mechanism involves modifications of genome-bound histone proteins ... methylation). It acts on top of the genetic information ...
(Date:9/2/2014)... the September issue of The FASEB Journal ... to diagnose the leading cause of blindness in ... occurred. This advance involves quantifying the early molecular ... retinal vessels. Using new probes developed by scientists, ... development of diabetic retinopathy. , "My goal is ...
Breaking Biology News(10 mins):Scripps Florida scientists make diseased cells synthesize their own drug 2Throwing a loop to silence gene expression 2Molecular probes permit doctors to detect diabetic retinopathy before vision fails 2
... May 12, 2010 In findings that should finally ... of neurobiology, a team at The Scripps Research Institute has ... active in a brain region known to play a key ... formation. The new study also shows that this system can ...
... reporting success in a first attempt to silence the ... forces and cause infections. In a study in ACS, ... specially designed plastic-like materials to soak up the substances ... messages. Elena Piletska and colleagues point out ...
... flight May 14 carrying three University of Colorado at ... understand how and why slimy and troublesome clumps of ... The experiments on biofilms -- clusters of ... surfaces -- are of high interest to space scientists ...
Cached Biology News:Scripps Research study overturns decade-old findings in neurobiology 2Scripps Research study overturns decade-old findings in neurobiology 33 payloads built by CU-Boulder set for launch on space shuttle Atlantis 23 payloads built by CU-Boulder set for launch on space shuttle Atlantis 3